These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Taxanes in ovarian cancer treatment.
    Author: Seetalarom K, Kudelka AP, Verschraegen CF, Kavanagh JJ.
    Journal: Curr Opin Obstet Gynecol; 1997 Feb; 9(1):14-20. PubMed ID: 9090476.
    Abstract:
    Paclitaxel and docetaxel are active in the treatment of patients with advanced ovarian cancer. The taxanes in various dose schedules achieve response rates of 10-50% with a median overall survival of 10-12 months in patients with platinum-refractory disease. Paclitaxel has activity in chemotherapy-naive patients when administered alone or in combination with platinum. The role of intraperitoneal paclitaxel remains to be defined.
    [Abstract] [Full Text] [Related] [New Search]